HCC patients with lower ADH4 showed a worse overall survival rate compared with those with high expression (P < 0.001), and the expression of ADH4 was an independent predictor of overall survival (HR, 0.154; 95% CI, 0.044-0.543; P = 0.004). The gene discussed is ADH4; the disease is hepatocellular carcinoma.